Created in 2000 (United States), Streptavidin Plus own 274 sister brands and 2617 competing brands. Streptavidin Plus is a brand of Agilent Technologies, Inc., listed on the stock exchange of New York. Streptavidin Plus is part of the Medical Diagnostics & Research activity sector.
Investment simulator :
Portfolio valuation
Agilent Technologies, Inc.
(Streptavidin Plus)
over 5 years*
USD 242.74